Covid-19 live updates: Fully vaccinated U.S. citizens are low-risk to travel, CDC says
Here are some significant developments:
- Pharmaceutical giant AstraZeneca faced new challenges to its coronavirus vaccine as Britain’s medicines regulator said that it found 30 cases of rare blood clots after the shot’s use. The company’s vaccine also has a new name in Europe: Vaxzevria.
- Europe is heading into its second locked-down Easter weekend amid fears that family gatherings could fuel a growing new wave of infections with vaccinations still lagging.
- A new government report says the United States spent $162 million getting Gilead’s covid-19 drug remdesivir to market but opted against seeking government patents because Gilead invented the experimental medicine years earlier.
- Anthony S. Fauci, the United States’ top infectious-disease specialist, on Friday shrugged off recent attacks by some members of Congress, responding with a mild zinger that compared progress against the coronavirus during the Biden and Trump administrations.
- The U.S. economy added 916,000 jobs in March, as vaccine distribution improved, Congress approved a $1.9 trillion stimulus package, and states across the country lifted restrictions on businesses.
- Britain said Friday it was adding four more countries to a travel ban “red list” due to growing concern over the threat from new coronavirus variants first identified in South Africa and Brazil.
Source: WP
